Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 11 studies | 36% ± 18% | |
oligodendrocyte precursor cell | 7 studies | 38% ± 19% | |
glutamatergic neuron | 6 studies | 40% ± 20% | |
astrocyte | 6 studies | 27% ± 11% | |
epithelial cell | 5 studies | 26% ± 4% | |
retinal bipolar neuron | 4 studies | 22% ± 4% | |
interneuron | 4 studies | 36% ± 17% | |
endothelial cell | 3 studies | 25% ± 4% | |
retinal cone cell | 3 studies | 21% ± 5% | |
rod bipolar cell | 3 studies | 23% ± 6% | |
transit amplifying cell | 3 studies | 24% ± 8% | |
goblet cell | 3 studies | 18% ± 2% | |
GABAergic neuron | 3 studies | 39% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 2269.32 | 180 / 180 | 100% | 12.66 | 430 / 430 |
brain | 100% | 2545.10 | 2641 / 2642 | 100% | 18.28 | 705 / 705 |
prostate | 100% | 1346.39 | 245 / 245 | 99% | 13.12 | 498 / 502 |
thymus | 100% | 2065.76 | 653 / 653 | 99% | 14.35 | 596 / 605 |
breast | 100% | 894.44 | 459 / 459 | 98% | 11.01 | 1100 / 1118 |
intestine | 100% | 1780.55 | 966 / 966 | 98% | 12.28 | 517 / 527 |
stomach | 100% | 1343.40 | 358 / 359 | 98% | 12.76 | 279 / 286 |
pancreas | 98% | 724.69 | 323 / 328 | 98% | 11.44 | 175 / 178 |
kidney | 100% | 2020.66 | 89 / 89 | 97% | 14.35 | 871 / 901 |
lung | 98% | 954.65 | 569 / 578 | 98% | 9.53 | 1133 / 1155 |
bladder | 100% | 1171.76 | 21 / 21 | 96% | 8.72 | 485 / 504 |
esophagus | 97% | 864.94 | 1398 / 1445 | 99% | 12.87 | 182 / 183 |
uterus | 100% | 1244.75 | 170 / 170 | 95% | 8.08 | 435 / 459 |
skin | 100% | 1021.05 | 1800 / 1809 | 92% | 13.05 | 435 / 472 |
adrenal gland | 100% | 1347.05 | 258 / 258 | 91% | 8.19 | 209 / 230 |
liver | 98% | 1006.61 | 222 / 226 | 79% | 5.30 | 322 / 406 |
spleen | 100% | 2242.39 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.10 | 1 / 1 |
blood vessel | 100% | 1421.40 | 1333 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 907.91 | 1195 / 1204 | 0% | 0 | 0 / 0 |
muscle | 95% | 601.36 | 761 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 7.27 | 42 / 45 |
heart | 90% | 616.94 | 778 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 5.95 | 25 / 29 |
eye | 0% | 0 | 0 / 0 | 57% | 3.30 | 46 / 80 |
peripheral blood | 31% | 241.10 | 284 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048874 | Biological process | host-mediated regulation of intestinal microbiota composition |
GO_0001523 | Biological process | retinoid metabolic process |
GO_0070291 | Biological process | N-acylethanolamine metabolic process |
GO_0090336 | Biological process | positive regulation of brown fat cell differentiation |
GO_0001659 | Biological process | temperature homeostasis |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0070292 | Biological process | N-acylphosphatidylethanolamine metabolic process |
GO_0009395 | Biological process | phospholipid catabolic process |
GO_0043227 | Cellular component | membrane-bounded organelle |
GO_0005769 | Cellular component | early endosome |
GO_0031901 | Cellular component | early endosome membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005635 | Cellular component | nuclear envelope |
GO_0000139 | Cellular component | Golgi membrane |
GO_0042622 | Cellular component | photoreceptor outer segment membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0070290 | Molecular function | N-acylphosphatidylethanolamine-specific phospholipase D activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0032052 | Molecular function | bile acid binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | NAPEPLD |
Protein name | NAPEPLD protein N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (N-acyl phosphatidylethanolamine phospholipase D) (NAPE-PLD) (NAPE-hydrolyzing phospholipase D) (EC 3.1.4.54) N-acyl phosphatidylethanolamine phospholipase D (N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D) |
Synonyms | C7orf18 |
Description | FUNCTION: D-type phospholipase that hydrolyzes N-acyl-phosphatidylethanolamines (NAPEs) to produce bioactive N-acylethanolamines/fatty acid ethanolamides (NAEs/FAEs) and phosphatidic acid . Cleaves the terminal phosphodiester bond of diacyl- and alkenylacyl-NAPEs, primarily playing a role in the generation of long-chain saturated and monounsaturated NAEs in the brain (By similarity). May control NAPE homeostasis in dopaminergic neuron membranes and regulate neuron survival, partly through RAC1 activation (By similarity). As a regulator of lipid metabolism in the adipose tissue, mediates the crosstalk between adipocytes, gut microbiota and immune cells to control body temperature and weight. In particular, regulates energy homeostasis by promoting cold-induced brown or beige adipocyte differentiation program to generate heat from fatty acids and glucose. Has limited D-type phospholipase activity toward N-acyl lyso-NAPEs (By similarity). . |
Accessions | ENST00000611100.2 ENST00000427257.5 ENST00000418294.1 ENST00000633498.1 ENST00000633771.1 ENST00000633783.1 ENST00000420631.5 ENST00000341533.8 ENST00000632159.1 H0Y4Y2 Q4G0T7 ENST00000465647.6 ENST00000622712.4 ENST00000422589.5 Q6IQ20 ENST00000632703.1 C9JGB1 ENST00000417955.5 |